• Other CEVA web sites
Home
CARDIO SYMPOSIUM 2009
  • Program
  • Sessions
  • Speakers
Home > Cardiology Symposium 2009-Program > Sessions > Overexpression of the mineralocorticoid receptors: pathophysiological consequences

  • Frédéric Jaisser

    Frédéric Jaisser

    MD, PhD Research Director - INSERM (French National Institute of Health and Medical Research). Paris, France Contact : frederic.jaisser@crc.jussieu.fr
    ►Read more...

See all experts

 

<<
  • Martin Mitchell at 1st Human and Veterinary Crossover Symposium on Aldosterone, Bordeaux 2009

    Welcome Introduction Symposium

  • Aldosterone and mineralocortoid receptors: expanding views from the kidney to the cardiovascular system.

    Aldosterone and mineralocortoid receptors: expanding views from the kidney to the cardiovascular system.

  • Overexpression of the mineralocorticoid receptors: pathophysiological consequences

    Overexpression of the mineralocorticoid receptors: pathophysiological consequences

  • Questions and Answers

    Questions and Answers

  • Mineralocorticoid receptor blockade: how experimental evidence supports the clinical benefit

    Mineralocorticoid receptor blockade: how experimental evidence supports the clinical benefit

  • 1st Human and Veterinary Crossover Symposium on Aldosterone, Bordeaux 2009

    Questions and Answers

  • The proximate cause of heart failure: models, remodeling, and re-remodeling

    The proximate cause of heart failure: models, remodeling, and re-remodeling

  • 1st Human and Veterinary Crossover Symposium on Aldosterone, Bordeaux 2009

    Questions and Answers

  • After RALES, the journey continues

    After RALES, the journey continues

  • Questions and Answers

    Questions and Answers

  • Claudio Bussadori - Ceva cardiology Symposium, Bordeaux October 2009

    Efficacy of spironolactone in dogs with naturally occurring Myxomatous Mitral Valve Disease. (part I)

  • Claudio Bussadori at 1st Human and Veterinary Crossover Symposium on Aldosterone, Bordeaux 2009

    Efficacy of spironolactone in dogs with naturally occurring Myxomatous Mitral Valve Disease. (part II)

  • Martin Bland at 1st Human and Veterinary Crossover Symposium on Aldosterone, Bordeaux 2009

    Principles of survival analysis illustrated by CEVA’s spironolactone trials

  • Questions and Answers

    Questions and Answers

  • Faiez Zannad at 1st Human and Veterinary Crossover Symposium on Aldosterone, Bordeaux 2009

    Current clinical status and future directions for biomarkers in heart failure

  • Questions and Answers

    Questions and Answers

  • Marc Prikazsky at 1st Human and Veterinary Crossover Symposium on Aldosterone, Bordeaux 2009

    Conclusion Symposium

  • TEST

    TEST

>>

VISIT OUR SITES

  • ► www.cardiosymposium2011.ceva.com
  • ► www.cardioacademy.cevalearn.com
  • ► www.ceva.com
  • © CEVA Santé Animale 2021
  • Cookies Policy
  • Privacy
  • Sitemap
  • Legal Notice
  • Feedback on event
  • Feed back Comments
› Top